Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.57 |
| ▸ | TSHR | P16473 | 2/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.41 |
| ▸ | PNLIP | P16233 | 2/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.36 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.34 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | UGT2B7 | P16662 | 4/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15220009 | 1.00 | ALDH1A1 (0.57) | ALDH1A1MAPTCYP3A4CYP2C9TSHR | |
| SCHEMBL9549996 | 1.00 | ALDH1A1 (0.57) | ALDH1A1MAPTCYP3A4CYP2C9TSHR | |
| SCHEMBL541382 | 1.00 | ALDH1A1 (0.57) | ALDH1A1MAPTCYP3A4CYP2C9TSHR | |
| SCHEMBL9550004 | 1.00 | ALDH1A1 (0.57) | ALDH1A1MAPTCYP3A4CYP2C9TSHR | |
| SCHEMBL8731628 | 1.00 | ALDH1A1 (0.57) | ALDH1A1MAPTCYP3A4CYP2C9TSHR | |
| SCHEMBL25669585 | 1.00 | ALDH1A1 (0.57) | ALDH1A1MAPTCYP3A4CYP2C9TSHR | |
| SCHEMBL18949253 | 0.87 | ALDH1A1 (0.46) | ALDH1A1MAPTCYP3A4CYP2C9TSHR | |
| SCHEMBL9623433 | 0.86 | ALDH1A1 (0.62) | ALDH1A1MAPTCYP3A4CYP2C9TSHR | |
| SCHEMBL9623437 | 0.86 | ALDH1A1 (0.62) | ALDH1A1MAPTCYP3A4CYP2C9TSHR | |
| SCHEMBL8733677 | 0.86 | MAPT (0.44) | ALDH1A1MAPTCYP3A4CYP2C9TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10633314-B2 | Method for the conversion of Abienol to Sclarediol | GIVAUDAN S.A. (CH) | 2020-04-28 | — | — | US | disclosed |
| EP-3271343-B1 | METHOD FOR THE CONVERSION OF ABIENOL TO SCLAREDIOL | GIVAUDAN SA (CH) | 2019-10-09 | — | — | EP | disclosed |
| US-20180072644-A1 | Method for the Conversion of Abienol to Sclarediol | GIVAUDAN S.A. (CH) | 2018-03-15 | — | — | US | disclosed |
| US-20180072644-A1 | Method for the Conversion of Abienol to Sclarediol | GIVAUDAN S.A. (CH) | 2018-03-15 | — | — | US | disclosed |
| WO-2016146769-A1 | METHOD FOR THE CONVERSION OF ABIENOL TO SCLAREDIOL | GIVAUDAN SA (CH) | 2016-09-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180072644-A1 | Method for the Conversion of Abienol to Sclarediol | CYP51A1, CYP2A13, HSD17B13 | ALDH1A1 2371/4885MAPT 4821/4885CYP3A4 358/4885 |
| US-10633314-B2 | Method for the conversion of Abienol to Sclarediol | CYP51A1, CYP2A13, HSD17B13 | ALDH1A1 2371/4885MAPT 4821/4885CYP3A4 358/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.